- Reaction score
- 480
We don't have "hairloss pathways" we have hair growth pathways and they're being shut down. The main one being the Wnt pathway. There's good evidence to suggest the Wnt pathway is THE pathway when it comes to Androgenetic Alopecia, and that drugs that are capable of upregulating it, by some method of action, will be essentially an "override switch" turning back on all the hair follicle cells that have gone dormant. I think Wnt agonists have by far the most potential compared to any other drug approach being pursued atm.
The problem is you really want to target the pathway specific to the downregulation acting on HF Wnt signaling due to Androgenetic Alopecia, a blanket upregulation of Wnt signalling is not ideal considering over expression of this pathway is implicated with increased cancer risk.